NCT04775225

Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis

Hip Denervation in Juvenile Idiopathic Arthritis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 2 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

Patients having juvenile idiopathic arthritis (according to ILAR criteria) with hip arthritis were divided into 3 groups. Group 1 received hip denervation and group 2 controlled and received a subcutaneous injection of saline, and group 3 received intra-articular triamcinolone. Outcome measures included pain, tenderness, range of motion, SOLAR, HARISS score. These outcomes were measured at baseline, 2 weeks, and 16 weeks

Detailed description

The aim of the study is to test the effect of denervation of the active hip in JIA and compare it with a placebo without changing systemic treatment during the study. Outcome measures included pain, range of motion, SOLAR score, and Harris functional score.

Conditions

• Juvenile Idiopathic Arthritis
• Hip Arthritis

Interventions

Type	Name	Description
DRUG	Lidocaine	denervation of the obturator and femoral genicular branches by Lidocaine 2 %
DRUG	Placebo	an equivalent amount of saline will be injected subcutaneously in 2 points similar to the active group
DRUG	Steroid	Intra-articular injection of 80mg of triamcinolone

Timeline

• Start date: 2021-01-06
• Primary completion: 2021-04-06
• Completion: 2021-04-06
• First posted: 2021-03-01
• Last updated: 2023-01-17

Locations

1 site across 1 country: Egypt